Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here?

Novo Nordisk (NVO) stock extended gains on Friday after the pharmaceutical giant announced a partnership with Amazon Pharmacy for its FDA-approved oral weight-loss pill. 

According to its press release, Amazon Pharmacy will offer access to oral Wegovy at competitive price points starting at $25 for insured patients and $149 for uninsured customers. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.